Posttransplant recurrence of calcium oxalate crystals in patients with primary hyperoxaluria: Incidence, risk factors, and effect on renal allograft function. Issue 1 (26th July 2021)

• Record Type: Journal Article
• Authors: Cornell, Lynn D.; Amer, Hatem; Viehman, Jason K.; Mehta, Ramila A.; Lieske, John C.; Lorenz, Elizabeth C.; Heimbach, Julie K.; Stegall, Mark D.; Milliner, Dawn S.
• Is Part Of: American journal of transplantation. Volume 22:Issue 1(2022)
• Page Start: 85
• Page End: 95
• Publication Date: 2021-07-26
• Subjects: clinical research / practice -- kidney transplantation / nephrology -- protocol biopsy -- recurrent disease; Transplantation of organs, tissues, etc -- Periodicals; 617.95
• DOI: 10.1111/ajt.16732
• Languages: English
• ISSNs: 1600-6135

Abstract

Abstract : Primary hyperoxaluria (PH) is a metabolic defect that results in oxalate overproduction by the liver and leads to kidney failure due to oxalate nephropathy. As oxalate tissue stores are mobilized after transplantation, the transplanted kidney is at risk of recurrent disease. We evaluated surveillance kidney transplant biopsies for recurrent calcium oxalate (CaOx) deposits in 37 kidney transplants (29 simultaneous kidney and liver [K/L] transplants and eight kidney alone [K]) in 36 PH patients and 62 comparison transplants. Median follow‐up posttransplant was 9.2 years (IQR: [5.3, 15.1]). The recurrence of CaOx crystals in surveillance biopsies in PH at any time posttransplant was 46% overall (41% in K/L, 62% in K). Higher CaOx crystal index (which accounted for biopsy sample size) was associated with higher plasma and urine oxalate following transplant ( p < .01 and p < .02, respectively). There was a trend toward higher graft failure among PH patients with CaOx crystals on surveillance biopsies compared with those without (HR 4.43 [0.88, 22.35], p = .07). CaOx crystal deposition is frequent in kidney transplants in PH patients. The avoidance of high plasma oxalate and reduction of CaOx crystallization may decrease the risk of recurrent oxalate nephropathy following kidney transplantation in patients with PH. This study was approved by the IRB at Mayo Clinic. Abstract : This study of kidney transplant surveillance biopsies in patients with primary hyperoxaluria demonstrates the natural history of recurrent oxalate nephropathy.